E. ÖKSÜM SOLAK Et Al. , "Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-center Study," Erciyes Medical Journal , vol.43, pp.267-272, 2021
ÖKSÜM SOLAK, E. Et Al. 2021. Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-center Study. Erciyes Medical Journal , vol.43 , 267-272.
ÖKSÜM SOLAK, E., GÖKÇEK, G. E., ÇİNAR, S. L., KARTAL, D., & BORLU, M., (2021). Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-center Study. Erciyes Medical Journal , vol.43, 267-272.
ÖKSÜM SOLAK, EDA Et Al. "Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-center Study," Erciyes Medical Journal , vol.43, 267-272, 2021
ÖKSÜM SOLAK, EDA Ö. Et Al. "Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-center Study." Erciyes Medical Journal , vol.43, pp.267-272, 2021
ÖKSÜM SOLAK, E. Et Al. (2021) . "Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-center Study." Erciyes Medical Journal , vol.43, pp.267-272.
@article{article, author={EDA ÖKSÜM SOLAK Et Al. }, title={Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-center Study}, journal={Erciyes Medical Journal}, year=2021, pages={267-272} }